Cited 0 times in
Transrectal or Transvaginal Ultrasoundguided Biopsy for Pelvic Masses: External Validation and Usefulness in Oncologic Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 원소연 | - |
dc.contributor.author | 김현수 | - |
dc.contributor.author | 박성윤 | - |
dc.date.accessioned | 2020-07-01T07:00:51Z | - |
dc.date.available | 2020-07-01T07:00:51Z | - |
dc.date.issued | 2019-04 | - |
dc.identifier.issn | 2288-5919 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/176263 | - |
dc.description.abstract | Purpose: The purpose of this study was to externally validate the diagnostic usefulness of transrectal ultrasound (TRUS) or transvaginal ultrasound (TVUS)-guided biopsy for pelvic masses, and to analyze the diagnostic performance of these methods in oncologic patients. Methods: A consecutive series of 30 patients who underwent TRUS- or TVUS-guided biopsy for pelvic masses was included. Tissue samples were obtained using an 18-gauge core biopsy needle under local anesthesia for lesions detected on computed tomography or magnetic resonance imaging. We analyzed the rates of diagnostic biopsies upon pathologic examination and biopsy-related major complications requiring treatment. In diagnostic biopsy cases, the performance was also investigated for all patients and patients with underlying malignancy. Results: The diagnostic biopsy rate was 93.3% (28 of 30) for all patients and 95.0% (19 of 20) for oncologic patients. No patients had major complications. In diagnostic biopsies, the sensitivity, specificity, positive and negative predictive value, and accuracy for identifying malignancy were 100% (17 of 17), 72.7% (8 of 11), 85.0% (17 of 20), 100% (8 of 8), and 89.3% (25 of 28) for all patients and 100% (14 of 14), 60.0% (3 of 5), 87.5% (14 of 16), 100% (3 of 3), and 89.5% (17 of 19) for oncologic patients, respectively. Conclusion: This study externally validated the feasibility and safety of TRUS- or TVUS-guided biopsy. In addition, these techniques appear to enable accurate pathologic diagnoses of pelvic masses in oncologic patients to be made safely and relatively noninvasively. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Society of Ultrasound in Medicine | - |
dc.relation.isPartOf | ULTRASONOGRAPHY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Transrectal or Transvaginal Ultrasoundguided Biopsy for Pelvic Masses: External Validation and Usefulness in Oncologic Patients | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Radiology (영상의학교실) | - |
dc.contributor.googleauthor | So Yeon Won | - |
dc.contributor.googleauthor | Hyun-Soo Kim | - |
dc.contributor.googleauthor | Sung Yoon Park | - |
dc.identifier.doi | 10.14366/usg.18028 | - |
dc.contributor.localId | A05910 | - |
dc.contributor.localId | A01114 | - |
dc.contributor.localId | A01509 | - |
dc.relation.journalcode | J02768 | - |
dc.identifier.eissn | 2288-5943 | - |
dc.identifier.pmid | 30153726 | - |
dc.subject.keyword | Biopsy | - |
dc.subject.keyword | Pelvis | - |
dc.subject.keyword | Transrectal | - |
dc.subject.keyword | Transvaginal | - |
dc.subject.keyword | Ultrasound | - |
dc.contributor.alternativeName | Won, So Yeon | - |
dc.contributor.affiliatedAuthor | 원소연 | - |
dc.contributor.affiliatedAuthor | 김현수 | - |
dc.contributor.affiliatedAuthor | 박성윤 | - |
dc.citation.volume | 38 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 149 | - |
dc.citation.endPage | 155 | - |
dc.identifier.bibliographicCitation | ULTRASONOGRAPHY, Vol.38(2) : 149-155, 2019-04 | - |
dc.identifier.rimsid | 64469 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.